Press release
Osteomalacia Drugs Market Analysis, Growth Opportunities and Latest Trends By Leading Regions, And Manufacturers by 2025
In the recent times, the global market for osteomalacia drugs has gained a significant momentum, owing to the rising prevalence of osteomalacia across the world. Disorders caused by the deficiency of vitamin D and mineral deficiency cause osteomalacia in humans.
Read Report Overview - https://www.transparencymarketresearch.com/osteomalacia-drugs-market.html
Cancer, liver diseases, autoimmune disorders, several drugs, such as phenytoin and phenobarbital, and certain surgeries, such as stomach surgery, can also cause osteomalacia. With the advancements in the drugs to increase their efficiency, this market is likely to report healthy growth over the next few years.
This report is aimed at offering a thoroughly assessed study of the global market for osteomalacia drugs, focusing on the growth drivers, obstructions, challenges, opportunities, market trends, and future potentials.
Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=42143
Global Osteomalacia Drugs Market: Trends and Opportunities
The augmenting number of people suffering from osteomalacia and rickets across the world is driving the global osteomalacia drugs market, significantly. In addition to this, the easy availability of novel drugs, such as burosumab and parathyroid hormone (PTH) for the treatment of pediatric and adult patients having hypophosphatemia is also fueling the demand for osteomalacia drugs. The U.S. FDA granted the breakthrough therapy designation to Asfotase Alfa in 2015, which is anticipated to support the global market over the next few years.
Global Osteomalacia Drugs Market: Regional Outlook
On the basis of the geography, the global market for osteomalacia drugs t can be categorized into five regions, which are North America, Asia Pacific, Europe, Latin America, and the Middle East and Africa. Among these, North America has been dominant and is expected to remain so over the next few years, thanks to a well-developed healthcare infrastructure, an increasing demand for vitamin D, constantly changing lifestyle, and the rising expenditure on medical and healthcare in the region.
Request for Custom Research - https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=42143
According to a report, around 40% of the overall U.S. population is suffering from the deficiency of vitamin D, which is why the country demonstrates such high prevalence of bone-related disorders. With the increasing awareness among consumers regarding various types of bone disorders and the easy availability of highly-advanced technologies, the North America market for osteomalacia drugs is likely to witness significant growth in the years to come.
Europe is anticipated to retain its second number position in the overall market over the period from 2017 to 2025, thanks to the increased investments for research and development by the governments in this region. The Asia Pacific market is predicted to observe a healthy rise in the near future, owing to the ongoing development in the medical and healthcare infrastructure in prominent Asian economies and the presence of a large patient pool in this region. Other regional markets, such as Latin America and the Middle East and Africa, are also expected to report a steady rise in the years to come.
Pre Book Osteomalacia Drugs Market Report at https://www.transparencymarketresearch.com/checkout.php?rep_id=42143<ype=S
Companies Mentioned in the Report
Due to the presence of a large pool of local as well as international participants, the vendor landscape in the global market for osteomalacia drugs is fragmented and highly competitive. Some of the most prominent vendors of osteomalacia drugs across the world are Kyowa Hakko Kirin International plc, Zeria Pharmaceutical Co. Ltd., Alexion Pharmaceuticals, Pfizer Inc., GlaxoSmithKline plc, Sun Pharmaceutical Industries Ltd., Mankind Pharma, Pharmavite LLC, Chemvon Biotechnology (Shanghai) Co. Ltd., and Abbott Laboratories.
More Trending Reports by Transparency Market Research –
Myasthenia Gravis Market: https://www.prnewswire.com/news-releases/continual-medical-research-for-improved-treatment-underscores-growth-in-myasthenia-gravis-market-growth-projected-at-notable-8-cagr-through-2027-tmr-301334546.html
Please Subscribe to Our Youtube Channel for More Industry Research Insights - https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ/videos
Contact
Transparency Market Research,
90 State Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com/
About Us
Transparency Market Research is a global market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for several decision makers. Our experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
Our data repository is continuously updated and revised by a team of research experts so that it always reflects latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Osteomalacia Drugs Market Analysis, Growth Opportunities and Latest Trends By Leading Regions, And Manufacturers by 2025 here
News-ID: 2468651 • Views: …
More Releases from Transparency Market Research
Cloud Artificial Intelligence (AI) Solutions Market Poised for Exponential Growt …
The Global Cloud Artificial Intelligence (AI) Solutions Market (클라우드 인공지능(AI) 솔루션 시장) is set for remarkable growth, with projections indicating a leap from $38.1 billion in 2022 to an estimated $254.6 billion by 2031. This represents a robust compound annual growth rate (CAGR) of 24.1% over the forecast period of 2023 to 2031. The rapid expansion of the market reflects the transformative potential of cloud-based AI technologies across diverse industries.
Cloud-based…
Global Smart Agriculture Market Poised for Significant Growth, Expected to Excee …
The Global Smart Agriculture Market (スマート農業市場), valued at approximately US$ 10.02 billion in 2020, is set to experience robust expansion, with an anticipated compound annual growth rate (CAGR) of 13.30% from 2021 to 2031. Market analysts project that the sector will surpass US$ 39.02 billion by the end of the forecast period, driven by advancements in technology and increasing adoption of digital solutions in farming practices.
Download Sample PDF from Here-…
Real-Time Flood Monitoring & Warning System Market Expected to Grow at 6.2% CAGR …
The Global Real-Time Flood Monitoring and Warning System Market (실시간 홍수 모니터링 및 경고 시스템 시장), valued at over USD 184.1 million in 2020, is set to witness substantial growth over the next decade. According to industry analysts, the market is expected to expand at a compound annual growth rate (CAGR) of 6.2% from 2021 to 2031, ultimately surpassing USD 359.5 million by the end of the forecast period.
The increasing…
Global Asset and Wealth Management Market Set for Explosive Growth, Projected to …
The Global Asset and Wealth Management Market (資産および資産管理市場), valued at US$ 3.5 billion in 2021, is projected to expand at a robust CAGR of 13.0% from 2022 to 2031, reaching a market value of US$ 11.8 billion by the end of the forecast period.
The asset and wealth management industry is witnessing rapid evolution, spurred by the integration of advanced technologies, regulatory changes, and shifting investor demographics. As technology plays an…
More Releases for Osteomalacia
Tumour-Induced Osteomalacia Market Expected to Witness the Highest Growth by 203 …
Tumour-induced osteomalacia or oncogenic osteomalacia is a rare paraneoplastic syndrome of bone which consist of osteomalacia or rickets induced by phosphaturic mesenchymal tumour (PMT). Tumour-induced osteomalacia diagnosed with an elevated level of blood fibroblast growth factor 23 (FGF23), phosphate and vitamin D-regulating hormone. According to Maastricht University Hospital research, paraneoplastic syndrome affects 8% of cancer patients.
Get In-depth Insights Request for Brochure here: https://www.factmr.com/connectus/sample?flag=B&rep_id=5255
Through the new research report, analysts focus…
Bone and Mineral Disorders Market Is Expected To Grow At A Rapid Pace Throughout …
Acumen Research and Consulting has announced the addition of the "Bone and Mineral Disorders Market” report to their offering.
The Bone and Mineral Disorders Market Report 2018 is an in depth study analyzing the current state of the Bone and Mineral Disorders Market. It provides brief overview of the market focusing on definitions, market segmentation, end-use applications and industry chain analysis. The study on Bone and Mineral Disorders Market provides analysis…
Vitamins Market Forecast to 2027 – Koninklijke DSM N.V.,, Glanbia plc, The Arc …
A vitamin is one of a group of organic substances that is present in minute amounts in natural foodstuff. Vitamins are derived from food and essential for normal metabolism in order to sustain healthy life. Vitamins are either water-soluble or fat-soluble. Vitamin deficiency can cause various health problems such as night blindness, risk of maternal mortality, rickets, osteomalacia etc. Prevalence of vitamin deficiency across the globe is expected to drive…
Vitamin D Market 2018 : Archer Daniels Midland Company, Abbott Laboratories, BAS …
The global Vitamin D market size is projected to surpass $xx Billion rising at a CAGR of xx% in terms of volume over the forecast period. Major factors driving Vitamin D market are increasing cases of rickets & concerns about vitamin D deficiency, increasing cases of Osteoporosis & Osteomalacia as well as child malnourishment. On the other hand, stringent regulatory standards over Vitamin D Toxicity as well as lack of…
Extensive Research on the Roles of Vitamin D to Boost Growth of its Global Marke …
Vitamin D is a group of chemical compounds essential for human body to maintain various function such as metabolism. It can be naturally found in food such as fish, egg yolk, mushroom, and liver oil and commonly used in nutritional supplements and in pharmacies in dosage forms. While vitamin D is required for normal growth, development of bone and teeth, regulation of heart, and other, its deficiency could lead to…
Osteomalacia Drugs Market to Record Sturdy Growth by 2025
In the recent times, the global Osteomalacia Drugs Market has gained a significant momentum, owing to the rising prevalence of osteomalacia across the world. Disorders caused by the deficiency of vitamin D and mineral deficiency cause osteomalacia in humans. Cancer, liver diseases, autoimmune disorders, several drugs, such as phenytoin and phenobarbital, and certain surgeries, such as stomach surgery, can also cause osteomalacia. With the advancements in the drugs to increase…
